Fierce Pharma
DECEMBER 5, 2024
AstraZeneca has picked off another label expansion for cancer blockbuster Imfinzi as the FDA has blessed it for limited-stage small cell lung cancer.
MedCity News
DECEMBER 5, 2024
The startup’s first disease target is chronic inflammatory demyelinating polyneuropathy (CIDP), which can be treated with a blockbuster Argenx drug. Nuvig aims to show its drug can offer a better way to treat this disease and other autoimmune conditions. The post Nuvig Therapeutics Nabs $161M to Build Case for a Better Approach to Autoimmune Disease appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
DECEMBER 5, 2024
MedCity News
DECEMBER 5, 2024
Many providers are still struggling to recover from the workforce crisis that emerged during the pandemic, two healthcare leaders said during a recent panel. The post Where Does Healthcares Workforce Crisis Stand? appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
DECEMBER 5, 2024
Novartis’ latest effort to block a generic challenger to blockbuster heart med Entresto has come up short, this time in a federal appeals court. | The U.S. Court of Appeals for the Federal Circuit sided with a prior ruling that denied Novartis' motion seeking an injunction to prevent MSN's generic rival from launching.
PharmaTimes
DECEMBER 5, 2024
New antibody therapy shows promise in managing condition
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaTimes
DECEMBER 5, 2024
Phase 3 trial indicates significant efficacy and safety for children and adolescents
Fierce Pharma
DECEMBER 5, 2024
pharmaphorum
DECEMBER 5, 2024
Many patients can expect a long wait for access to Eli Lilly's obesity shot Mounjaro, even though it has been recommended for routine NHS use by NICE
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
DECEMBER 5, 2024
An appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic of its heart failure blockbuster Entresto.
MedCity News
DECEMBER 5, 2024
Healthcare needs a better way to collect information from all sources, organize it, summarize it and present it to providers in a way that lets them deliver the necessary treatment, confident that the material is sound and verifiable. The post How the Right AI Can Improve Health Risk Assessments appeared first on MedCity News.
pharmaphorum
DECEMBER 5, 2024
Investigations continue into the death of UnitedHealth chief executive Brian Thompson, who was shot and killed by an unknown assailant in New York
MedCity News
DECEMBER 5, 2024
StretchDollar’s $6 million raise was led by Fika Ventures and Oscar Health and included participation from Precursor Ventures and Springbank. The post ICHRA Startup Secures $6M to Streamline Health Benefits for Small Businesses appeared first on MedCity News.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
DECEMBER 5, 2024
AstraZeneca's Imfinzi becomes the first cancer immunotherapy to be FDA-approved for limited-stage small cell lung cancer (LS-SCLC)
Pharma Marketing Network
DECEMBER 5, 2024
Table of Contents Sr# Headings 1 Introduction: The Power of Marketing Networks 2 What Are Marketing Networks? 3 The Importance of Marketing Networks in Pharma 4 Building Healthcare Professional (HCP) Networks 5 Patient Advocacy Groups: A Trusted Connection 6 Digital Marketing Networks in Pharma 7 Branded Campaigns and Marketing Networks 8 Overcoming Challenges in Marketing Networks 9 The Role of Data in Strengthening Networks 10 Future Trends in Marketing Networks 11 Practical Tips for Pharma Ma
pharmaphorum
DECEMBER 5, 2024
Merus has its first approval for a commercial product, getting the go-ahead from the FDA for Bizengri, a first-in-class therapy for cancer
Pharmaceutical Technology
DECEMBER 5, 2024
The FDA has granted accelerated approval to Merus’ Bizengri in the treatment of advanced, unresectable NG1+ lung and pancreatic cancers.
PharmaVoice
DECEMBER 5, 2024
While developing its first-in-class gastric cancer drug Vyloy, Astellas had to coordinate with another pharma giant to usher the precision med into the market.
Pharmaceutical Technology
DECEMBER 5, 2024
Dewpoint Therapeutics and MTPC have entered a strategic research partnership focusing on the development of TDP-43 small molecule c-mod.
Pharmacy Times
DECEMBER 5, 2024
The data support the use of supportive anemia care agents in combination with ruxolitinib (Jakafi; Incyte Corp).
Pharmaceutical Technology
DECEMBER 5, 2024
LEO Pharma has gained marketing authorisation from the MHRA for Anzupgo to treat chronic hand eczema (CHE) in Great Britain.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmacy Times
DECEMBER 5, 2024
During a 15-year period, 1 in 5 older adults living with COPD received a shingles vaccine.
Pharmaceutical Technology
DECEMBER 5, 2024
The US FDA has approved AstraZeneca's Imfinzi (durvalumab), to treat limited-stage small cell lung cancer (LS-SCLC) in the adult population.
Pharmacy Times
DECEMBER 5, 2024
Fabry disease is a rare lysosomal disorder that causes excessive deposition of lipids in tissues.
Pharmaceutical Commerce
DECEMBER 5, 2024
Is the potential of a more formal policy integration for health issues and disease prevention a scary suggestion or a good Idea?
Pharmacy Times
DECEMBER 5, 2024
Zenocutuzumab-zbco is a bispecific antibody that targets and binds to HER2 and HER3.
Contrarian Sales Techniques
DECEMBER 5, 2024
If youve ever considered a career in medical sales for a multinational pharmaceutical company (MNC), youve probably heard a mix of storiessome inspiring, others downright intimidating. While this field offers exciting opportunities, its also shrouded in myths that may discourage potential candidates. Lets set the record straight by debunking 5 common myths about working in medical sales for MNCs in Malaysia.
Pharmaceutical Commerce
DECEMBER 5, 2024
While the program could be a good option for many, it's not a panacea.
PharmExec
DECEMBER 5, 2024
Approval of Imfinzi was based on results from the ADRIATIC Phase III trial, marking the first systemic immunotherapy available for limited-stage small cell lung cancer.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
259 
Let's personalize your content